Gout and risk for subsequent coronary heart disease: The Meharry- Hopkins study

Archives of Internal Medicine

Volumn 157, Issue 13, 1997, Pages 1436-1440

  Gelber, Allan C ^a,g   Klag, Michael J ^a   Mead, Lucy A ^a   Thomas, John ^b   Thomas, D Johniene ^b   Pearson, Thomas A ^c,f   Hochberg, Marc C ^d,e  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b MEHARRY MEDICAL COLLEGE   (United States)

^c BASSETT RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^e BALTIMORE VA MEDICAL CENTER   (United States)

^f UNIVERSITY OF ROCHESTER   (United States)

^g NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; GOUT; HUMAN; HYPERURICEMIA; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

EID: 0030757184     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.157.13.1436     Document Type: Article

References (23)

1. Gertler MM, Garn SM, Levine SA. Serum uric acid in relation to age and physique in health and in coronary heart disease. Ann Intern Med. 1951;34:1421-1431.
2. Klein R, Klein BE, Cornoni JC, Maready J, Cassel JC, Tyroler HA. Serum uric acid: its relationship to coronary heart disease risk factors and cardiovascular disease, Evans County, Georgia. Arch Intern Med. 1973;132:401-410.
3. Yano K, Rhoads GG, Kagan A. Epidemiology of serum uric acid among 8000 Japanese-American men in Hawaii. J Chronic Dis. 1977;30:171-184.
4. Goldbourt U, Medalie JH, Herman JB, Neufeld HN. Serum uric acid: correlation with biochemical, anthropometric, clinical and behavioral parameters in 10,000 Israeli men. J Chronic Dis. 1980;33:435-443.
5. Brand FN, McGee DL, Kannel WB, Stokes J, Castelli WP. Hyperuricemia as a risk factor of coronary heart disease: the Framingham Study. Am J Epidemiol. 1985; 121:11-18.
6. Freedman DS, Williamson DF, Gunter EW, Byers T. Relation of serum uric acid to mortality and ischemic heart disease: the NHANES I Epidemiology Follow-up Study. Am J Epidemiol. 1995;141:637-644.
7. Silman AJ, Hochberg MC. Epidemiology of the Rheumatic Diseases. Oxford, England: Oxford University Press; 1993:289-314.
8. Thomas CB. Observations on some possible precursors of essential hypertension and coronary artery disease. Bull Johns Hopkins Hosp. 1951;89:419-441.
9. Thomas J, Semenya KA, Neser WB, Thomas DJ, Green DR, Gillum RF. Risk factors and the incidence of hypertension in black physicians: the Meharry Cohort Study. Am Heart J. 1988;110:637-645.
10. Roubenoff R, Klag MJ, Mead LA, Liang K, Seidler AJ, Hochberg MC. Incidence and risk factors for gout in white men. JAMA. 1991;266:3004-3007.
11. Hochberg MC, Thomas J, Thomas DJ, Mead L, Levine DM, Klag MJ. Racial differences in the incidence of gout: the role of hypertension. Arthritis Rheum. 1995; 38:628-632.
12. Wallace SL, Robinson H, Masi AT, Decker JL, McCarty DJ, Yu T. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum. 1977;20:895-900.
13. Lipid Research Clinics Program. The Lipid Research Clinics Coronary Primary Prevention Trial results, I: reduction in incidence of coronary heart disease. JAMA. 1984;251:351-364.
14. International Classification of Diseases, Ninth Revision, Clinical Modification. Washington, DC: Public Health Service, US Dept of Health and Human Services; 1980:1.
15. Cox DR. Regression models and life-tables. J R Stat Soc. 1972;34:187-202.
16. Abbott RD, Brand FN, Kannel WB, Castelli WP. Gout and coronary heart disease: the Framingham Study. J Clin Epidemiol. 1988;41:237-242.
17. Fessel WJ. High uric acid as an indicator of cardiovascular disease: independence from obesity. Am J Med. 1980;68:401.
18. Ginsberg MH, Kozin F, O'Malley M, McCarthy DJ. Release of platelet constituents by monosodium urate crystals. J Clin Invest. 1977;60:999-1007.
19. Mustard JF, Murphy EA, Ogryzlo MA, Smythe HA. Blood coagulation and platelet economy in subjects with primary gout. Can Med Assoc J. 1963;89:1207-1211.
20. Newland H. Hyperuricemia in coronary, cerebral, and peripheral arterial disease: an explanation. Med Hypotheses. 1975;1:152-155.
21. Lee J, Sparrow D, Vokonas PS, Landsberg L, Weiss ST. Uric acid and coronary heart disease risk: evidence for a role of uric acid in the obesity-insulin resistance syndrome. Am J Epidemiol. 1995;142:288-294.
22. Messerli FH, Frohlich ED, Dreslinski GR, Suarez DH, Aristimuno GG. Serum uric acid in essential hypertension: an indicator of renal vascular involvement. Ann Intern Med. 1980;93:817-821.
23. Klag MJ, Ford DE, Mead LA, et al. Serum cholesterol in young men and subsequent cardiovascular disease. N Engl J Med. 1993;328:313-318.